Position in TLRY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$265,205
New position
Shares Held
40,990
first reported quarter
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ExodusPoint Capital Management, LP holds $58,166,201 across 15 Drug Manufacturers - Specialty & Generic names. TLRY ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
216,322 | $16,408,023 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
570,032 | $13,640,865 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
202,116 | $10,447,376 | |
| 4 | ALKS |
Alkermes plc.
|
204,324 | $7,224,896 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
52,303 | $2,518,389 | |
| 6 | PRGO |
PERRIGO Co plc
|
190,050 | $2,041,137 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
161,700 | $2,009,931 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
190,058 | $1,809,352 |
All Filings in TLRY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $265,205 | 40,990 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||